Dr. Noura Abul-Husn is the Vice President of Genomic Health at 23andMe. She oversees a team of clinical and scientific experts focused on building novel preventive health services and contributing to company-wide genetics and health initiatives that impact millions of consumers. Noura is a physician scientist who is known for pioneering genome-first approaches to provide novel clinical insights, inform therapeutic discovery, and implement genomic medicine programs tailored to ancestrally diverse populations. Throughout her career, she has led high-impact clinical, educational, and research programs that extend the reach of genomic medicine and personalized healthcare. Prior to joining 23andMe, she was the founding Chief of Genomic Medicine in the Department of Medicine and Clinical Director of the Institute for Genomic Health at Mount Sinai. Her work has been published in leading journals, including Science, Cell, and the New England Journal of Medicine. Noura completed her M.D. and Ph.D. degrees and residency at the Icahn School of Medicine at Mount Sinai in New York and is board certified in both Internal Medicine and Medical Genetics.